Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cognitive Synergy
AddedFeb 16, 2024
UpdatedJun 18, 2026
Cognitive Synergy

Cognitive Synergy

Seed

Cognitive Synergy: Advancing neuroscience research for Alzheimer's treatment, fostering collaboration, and educating communities.

HQ
California, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Cognitive Synergy is a research-based biopharmaceutical company dedicated to advancing neuroscience research, particularly in the treatment and prevention of Alzheimer's disease and other neurologic disorders. The company focuses on discovering and developing innovative medicines through cutting-edge technology and collaborative research. Cognitive Synergy aims to educate the community and serve as a resource by connecting patients, families, research centers, universities, and pharmaceutical companies.

Cognitive Synergy has made significant strides in the field of neurodegenerative disease research, contributing to the scientific understanding and potential treatment options for conditions like Alzheimer's. The company's collaborative approach has fostered partnerships with leading research institutions and pharmaceutical companies, enhancing its impact on the medical community. Through its innovative research and commitment to education, Cognitive Synergy continues to play a crucial role in the fight against neurologic disorders.

Cognitive Synergy - Similar Companies

NeuroCog Trials logo

NeuroCog Trials

Neuraly logo

Neuraly

neuralymed.com

NeuroX1 logo

NeuroX1

neurox1.com

NeuroGenetic Pharmaceuticals logo

NeuroGenetic Pharmaceuticals

Intellect Neurosciences logo

Intellect Neurosciences

Cajal Neuroscience logo

Cajal Neuroscience

cajalneuro.com

AivoCode logo

AivoCode

aivocode.com

Synchroneuron logo

Synchroneuron

Neurovia logo

Neurovia

Cognito Therapeutics logo

Cognito Therapeutics

cognitotx.com

Oscillo Biosciences logo

Oscillo Biosciences

BioHealthonomics logo

BioHealthonomics

Neurotrack logo

Neurotrack

neurotrack.com

Alto Neuroscience logo

Alto Neuroscience

CognitiveCare logo

CognitiveCare

cognitivecare.com

Cognitive Synergy - Quick Facts

Who are Cognitive Synergy's competitors?

Companies similar to Cognitive Synergy include NeuroCog Trials, Neuraly, NeuroX1 and NeuroGenetic Pharmaceuticals.

When was Cognitive Synergy founded?

Cognitive Synergy was founded in 2017.

Where is Cognitive Synergy's headquarters located?

Cognitive Synergy's headquarters is located in California, US.

When was Cognitive Synergy's last funding round?

Cognitive Synergy's most recent funding round was for $1.8M (USD) in January 2018.

How much has Cognitive Synergy raised to-date?

As of Jan 19, 2018, Cognitive Synergy has raised a total of $1.8M (USD).

How many employees does Cognitive Synergy have?

Cognitive Synergy has 30 employees as of Feb 4, 2024.

Cognitive Synergy - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Healthtech
  • Research
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified